WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

ALTERATION IN D-DIMER, ACTIVATED PARTIAL THROMBOPLASTIN TIME, THROMBOPLASTIN TIME, PLATELETS COUNT AND FIBRINOGEN AS HYPERCOAGULABILITY MARKERS IN PATIENTS WITH SOLID MALIGNANT TUMORS.

Awad Omer Ahmed, Khalid Mohammed Khalid, Mohammed Abdulgader Albasheer*

.

Abstract

Background: Activation of the coagulation cascade frequently occurs in cancer by a number of mechanisms, including the generation of tumor necrosis factor, tumor pro-coagulant and tissue factor. Aim: The purpose of this study was to investigate the plasma level of FIB, DD and evaluate the PT, INR, APTT, and platelets count in Sudanese patients with some solid malignant tumors. Methods: A total of 165 individuals (both sex 52% male and 48% female) of Sudan origin 125 patients diagnosed as solid malignant tumors (40% Breast, 24.8% Prostate, 10.4% uterine cervix, 7.2% rectum, 5.6% ovarian, 4,8% esophageal, 4.8% lungs and 2.4% colon) and 40 apparently healthy control subjects were prospectively enrolled in the study. The exclusion criteria of the study were the presence of a medical history of hematological malignancies or coagulation-related diseases, severe hepatic and/or renal insufficiency, significant cardiovascular disease, or receiving any anticoagulant therapy. Platelets were count by Sysmex Kx21, XRC used for PT, PTT, FIB and Snibe maglumi 2000 was used for D-dimer. Results: there were significant statistical differences between the study parameters in the patients compared with apparently healthy controls. The mean of (platelets count, PT, INR and APTT) was (295±125)cell/L, (22.9±2.82)sec, (1.49±0.206)% and (45.3±5.74) sec, in patients with solid malignant tumors vs (350±80.0) cell/L, (17.4±1.48)sec,(1.13±0.104)% and (38.0±5.28)sec in control group p-value (0.011), (0.000), (0.000) and( 0.000 ) respectively. Then mean value of D-dimer and FIB (297.9±75.1)mg/dl, (1.08±1.26) µg /ml in patients with solid malignant tumors vs (288.6±57.2) mg/dl, (0.482±0.223) µg /ml in control group p-value (0.409), (0.000) respectively. Conclusion: In this study, the study variables (Platelets count, PT, INR, APTT, and DD) show the significant statistical difference between the patients with some solid tumors and apparently healthy controls, but the FIB level results show insignificant different, our finding suggest that these study variables can play important role in pathogenesis of the hypercoagulable state in cancer patients the significant difference in platelets count, PT and APTT may early indication of bleeding tendency, further investigations (platelets function tests and coagulation factors assay) should be done to avoid risk of bleeding.

Keywords: Sysmex Kx21, XRC used for PT, PTT, FIB and Snibe maglumi 2000.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More